MCRB vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

MCRB

40.5
AI Score
VS
MCRB Wins

CLYM

32.1
AI Score

Investment Advisor Scores

MCRB

41score
Recommendation
HOLD

CLYM

32score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric MCRB CLYM Winner
Forward P/E 10.8225 0 Tie
PEG Ratio -0.11 0 Tie
Revenue Growth -93.4% 0.0% CLYM
Earnings Growth -91.9% 0.0% CLYM
Tradestie Score 40.5/100 32.1/100 MCRB
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation HOLD AVOID NEW MONEY MCRB

Relative Price Performance (Last 90 Days)

MCRB 1M: -40.1% · 3M: -68.1% CLYM 1M: +5.2% · 3M: -33.7%

Current Technical Phase

MCRB

Markdown
Sell / avoid

Price below a falling SMA50 (slope -27.1%), weak momentum, RSI 24

RSI (14): 23.5 · Price: $1.45

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.6 · Price: $10.83

Fundamentals Snapshot

Metric MCRB CLYM
Market Cap — —
Forward P/E -0.8 -12.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.9% 0.0%
Gross Margin -24.5% —
Operating Margin -21.0% 0.0%
EPS -5.01 -0.81
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, MCRB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.